Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

PDL BioPharma EPS - Earnings per Share 2006-2019 | PDLI

PDL BioPharma eps - earnings per share from 2006 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
PDL BioPharma Annual EPS
2018 $-0.47
2017 $0.71
2016 $0.39
2015 $2.03
2014 $1.86
2013 $1.66
2012 $1.45
2011 $1.15
2010 $0.54
2009 $1.07
2008 $0.47
2007 $-0.18
2006 $-0.84
2005 $-1.60
PDL BioPharma Quarterly EPS
Q1 2019 $0.05
Q4 2018 $0.10
Q3 2018 $0.18
Q2 2018 $-0.76
Q1 2018 $0.01
Q4 2017 $0.14
Q3 2017 $0.14
Q2 2017 $0.39
Q1 2017 $0.04
Q4 2016 $-0.06
Q3 2016 $0.08
Q2 2016 $0.03
Q1 2016 $0.34
Q4 2015 $0.64
Q3 2015 $0.42
Q2 2015 $0.47
Q1 2015 $0.50
Q4 2014 $0.29
Q3 2014 $0.61
Q2 2014 $0.52
Q1 2014 $0.44
Q4 2013 $0.32
Q3 2013 $0.36
Q2 2013 $0.62
Q1 2013 $0.36
Q4 2012 $0.32
Q3 2012 $0.32
Q2 2012 $0.52
Q1 2012 $0.29
Q4 2011 $0.24
Q3 2011 $0.28
Q2 2011 $0.38
Q1 2011 $0.25
Q4 2010 $-0.15
Q3 2010 $0.24
Q2 2010 $0.30
Q1 2010 $0.15
Q4 2009 $0.08
Q3 2009 $0.29
Q2 2009 $0.47
Q1 2009 $0.23
Q4 2008 $0.38
Q3 2008 $0.38
Q2 2008 $0.24
Q1 2008 $-0.53
Q4 2007 $-0.13
Q3 2007 $-0.05
Q2 2007 $0.09
Q1 2007 $-0.09
Q4 2006 $-0.78
Q3 2006 $-0.06
Q2 2006 $-0.06
Q1 2006 $-0.23
Q4 2005 $-0.31
Q3 2005 $-0.43
Q2 2005 $-0.03
Q1 2005 $-0.87
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.379B $0.198B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.995B 12.21
Gilead Sciences (GILD) United States $85.316B 10.36
Celgene (CELG) United States $64.087B 10.86
Vertex Pharmaceuticals (VRTX) United States $45.369B 54.84
Illumina (ILMN) United States $44.526B 51.60
Biogen (BIIB) United States $44.487B 8.44
CSL (CSLLY) Australia $35.586B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.719B 15.38
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.673B 15.66
Incyte (INCY) United States $17.204B 69.76
Exact Sciences (EXAS) United States $15.024B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.768B 0.00
SINO PHARMACEUT (SBMFF) China $14.154B 0.00
Seattle Genetics (SGEN) United States $12.157B 0.00
Sarepta Therapeutics (SRPT) United States $11.420B 0.00
Genmab (GNMSF) Denmark $11.291B 57.40
Array BioPharma (ARRY) United States $10.322B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.926B 29.32
Galapagos (GLPG) Belgium $8.704B 0.00
Guardant Health (GH) United States $8.043B 0.00
Bio-Techne Corp (TECH) United States $7.954B 54.27
Alnylam Pharmaceuticals (ALNY) United States $7.743B 0.00
Bluebird Bio (BLUE) United States $7.687B 0.00
Amarin (AMRN) Ireland $6.968B 0.00
Exelixis (EXEL) United States $6.551B 16.70
BeiGene (BGNE) Cayman Islands $5.653B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.786B 0.00
Ascendis Pharma (ASND) Denmark $4.751B 0.00
Blueprint Medicines (BPMC) United States $4.706B 0.00
Moderna (MRNA) United States $4.616B 0.00
Horizon Pharma Public (HZNP) Ireland $4.491B 11.57
Repligen (RGEN) United States $4.118B 102.59
Spark Therapeutics (ONCE) United States $3.727B 0.00
Mirati Therapeutics (MRTX) United States $3.724B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.686B 0.00
China Biologic Products (CBPO) China $3.670B 23.31
Alkermes (ALKS) Ireland $3.623B 0.00
MorphoSys AG (MOR) Germany $3.446B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.416B 0.00
Arena Pharmaceuticals (ARNA) United States $3.040B 6.18
Amicus Therapeutics (FOLD) United States $2.924B 0.00
Immunomedics (IMMU) United States $2.871B 0.00
UniQure (QURE) Netherlands $2.738B 0.00
Medicines (MDCO) United States $2.704B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.605B 0.00
Reata Pharmaceuticals (RETA) United States $2.529B 0.00
Halozyme Therapeutics (HALO) United States $2.439B 0.00
MyoKardia (MYOK) United States $2.295B 0.00
NeoGenomics (NEO) United States $2.282B 149.38
Nabriva Therapeutics AG (NBRV) Ireland $2.260B 0.00
Ligand Pharmaceuticals (LGND) United States $2.210B 18.31
Acceleron Pharma (XLRN) United States $2.199B 0.00
Emergent Biosolutions (EBS) United States $2.180B 18.93
Zai Lab (ZLAB) China $2.109B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.078B 0.00
Akcea Therapeutics (AKCA) United States $2.063B 0.00
Genomic Health (GHDX) United States $2.044B 43.42
Myriad Genetics (MYGN) United States $1.930B 19.20
Denali Therapeutics (DNLI) United States $1.917B 0.00
REGENXBIO (RGNX) United States $1.749B 0.00
Insmed (INSM) United States $1.672B 0.00
Cambrex (CBM) United States $1.510B 19.10
AnaptysBio (ANAB) United States $1.457B 0.00
Fate Therapeutics (FATE) United States $1.451B 0.00
RA PHARMCTL INC (RARX) United States $1.379B 0.00
Innoviva (INVA) United States $1.365B 3.78
Sangamo Therapeutics (SGMO) United States $1.364B 0.00
Athenex (ATNX) United States $1.286B 0.00
Alector (ALEC) United States $1.256B 0.00
Coherus BioSciences (CHRS) United States $1.233B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.187B 0.00
Editas Medicine (EDIT) United States $1.184B 0.00
Epizyme (EPZM) United States $1.142B 0.00
Cara Therapeutics (CARA) United States $1.070B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.023B 0.00
Codexis (CDXS) United States $1.022B 0.00
Twist Bioscience (TWST) United States $0.978B 0.00
Adverum Biotechnologies (ADVM) United States $0.978B 0.00
Principia Biopharma (PRNB) United States $0.974B 0.00
ANI Pharmaceuticals (ANIP) United States $0.973B 17.26
Momenta Pharmaceuticals (MNTA) United States $0.959B 0.00
Zymeworks (ZYME) Canada $0.940B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.924B 0.00
WAVE Life Sciences (WVE) Singapore $0.907B 0.00
Retrophin (RTRX) United States $0.879B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.866B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Vericel (VCEL) United States $0.853B 0.00
Arvinas (ARVN) United States $0.772B 0.00
Intellia Therapeutics (NTLA) United States $0.763B 0.00
Precision BioSciences (DTIL) United States $0.746B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.704B 33.22
Zealand Pharma (ZEAL) Denmark $0.704B 8.22
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Cytokineticsorporated (CYTK) United States $0.670B 0.00
Clovis Oncology (CLVS) United States $0.654B 0.00
Intra-Cellular Therapies (ITCI) United States $0.643B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.639B 0.00
Cellectis S.A (CLLS) France $0.635B 0.00
Heska (HSKA) United States $0.622B 63.73
DBV Technologies S.A (DBVT) France $0.596B 0.00
Anika Therapeutics (ANIK) United States $0.581B 19.84
Stemline Therapeutics (STML) United States $0.580B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.569B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.560B 0.00
Revance Therapeutics (RVNC) United States $0.557B 0.00
CytomX Therapeutics (CTMX) United States $0.549B 0.00
MiMedx (MDXG) United States $0.525B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
Mesoblast (MESO) Australia $0.494B 0.00
PHARMA MAR SA (PHMMF) Spain $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.445B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
Puma Biotechnology (PBYI) United States $0.405B 0.00
AC Immune SA (ACIU) Switzerland $0.398B 25.61
Prothena (PRTA) Ireland $0.389B 0.00
Arcus Biosciences (RCUS) United States $0.376B 0.00
Gritstone Oncology (GRTS) United States $0.372B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Biofrontera AG (BFRA) Germany $0.369B 0.00
Scholar Rock Holding (SRRK) United States $0.361B 0.00
Bellus Health (BLUSF) Canada $0.361B 0.00
Albireo Pharma (ALBO) United States $0.354B 0.00
Merus (MRUS) Netherlands $0.352B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.351B 0.00
Prometic Life Sciences (PFSCD) Canada $0.349B 0.00
BioDelivery Sciences (BDSI) United States $0.348B 0.00
Avid Bioservices (CDMO) United States $0.347B 0.00
Kadmon Holdings (KDMN) United States $0.344B 0.00
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
Agenus (AGEN) United States $0.340B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.333B 0.00
Acorda Therapeutics (ACOR) United States $0.332B 5.85
Senesco Technologies (ELOX) United States $0.331B 0.00
Theratechnologies (THERF) Canada $0.330B 0.00
Syros Pharmaceuticals (SYRS) United States $0.322B 0.00
Protagonist Therapeutics (PTGX) United States $0.310B 0.00
Sorrento Therapeutics (SRNE) United States $0.307B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.292B 0.00
Cellular Biomedicine (CBMG) United States $0.275B 0.00
Kindred Biosciences (KIN) United States $0.269B 0.00
Inovio Pharmaceuticals (INO) United States $0.266B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.261B 0.00
Sutro Biopharma (STRO) United States $0.253B 0.00
ChromaDex (CDXC) United States $0.253B 0.00
PHASEBIO PHARMA (PHAS) United States $0.249B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.248B 0.00
Dynavax Technologies (DVAX) United States $0.247B 0.00
Kamada (KMDA) Israel $0.241B 9.36
Athersys (ATHX) United States $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
Geron (GERN) United States $0.231B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.222B 0.00
Cel-Sci (CVM) United States $0.214B 0.00
CorMedix Inc (CRMD) United States $0.214B 0.00
Palatin Technologies (PTN) United States $0.211B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.206B 0.00
Cerecor (CERC) United States $0.199B 0.00
Five Prime Therapeutics (FPRX) United States $0.198B 0.00
Synlogic (SYBX) United States $0.196B 0.00
MannKind (MNKD) United States $0.195B 0.00
Abeona Therapeutics (ABEO) United States $0.193B 0.00
Mersana Therapeutics (MRSN) United States $0.191B 0.00
Affimed (AFMD) Germany $0.190B 0.00
Pfenex (PFNX) United States $0.187B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.185B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
Compugen (CGEN) Israel $0.183B 0.00
Arsanis (XFOR) United States $0.180B 0.00
Enzo Biochem (ENZ) United States $0.179B 0.00
BioTime (BTX) United States $0.169B 11.30
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.162B 0.00
XOMA (XOMA) United States $0.159B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.158B 0.00
Strongbridge Biopharma (SBBP) United States $0.157B 9.03
Cue Biopharma (CUE) United States $0.151B 0.00
Liquidia Technologies (LQDA) United States $0.144B 0.00
OvaScience (MLND) United States $0.142B 0.00
TOCAGEN INC (TOCA) United States $0.141B 0.00
Adocia (ADOCY) France $0.140B 0.00
Celyad SA (CYAD) Belgium $0.139B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Dyadic (DYAI) United States $0.133B 0.00
Seres Therapeutics (MCRB) United States $0.128B 0.00
NantKwest (NK) United States $0.125B 0.00
Aptinyx (APTX) United States $0.123B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.122B 0.00
Alcobra (ARCT) United States $0.119B 0.00
Aduro Biotech (ADRO) United States $0.118B 0.00
Arbutus Biopharma (ABUS) Canada $0.115B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Verastem (VSTM) United States $0.110B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
Menlo Therapeutics (MNLO) United States $0.108B 0.00
Novavax (NVAX) United States $0.107B 0.00
SESEN BIO, INC (SESN) United States $0.101B 0.00
Catalyst Biosciences (CBIO) United States $0.101B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.101B 0.00
Trevena (TRVN) United States $0.095B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.094B 0.00
Fortress Biotech (FBIO) United States $0.089B 0.00
Pluristem Therapeutics (PSTI) Israel $0.089B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.085B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.084B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.084B 0.00
Unum Therapeutics (UMRX) United States $0.079B 0.00
Selecta Biosciences (SELB) United States $0.078B 0.00
Curis (CRIS) United States $0.078B 0.00
AquaBounty Technologies (AQB) United States $0.076B 0.00
VBI Vaccines (VBIV) United States $0.076B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 38.80
Signal Genetics (MGEN) United States $0.070B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
ARAVIVE, INC (ARAV) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.061B 0.00
Antibe Therapeutics (ATBPF) Canada $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Invo BioScience (IVOB) United States $0.055B 0.00
NewLink Genetics (NLNK) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.051B 0.00